Author: fran
-
Our meeting with the DVLA and the changes announced
In response to overwhelming concerns from our community The Brain Tumour Charity met with the Driver and Vehicle Licensing Agency (DVLA) in Swansea to discuss issues around driving and brain tumours.
-
Exploiting metabolic pathways used by glioblastoma cells to halt tumour growth
A team at The Scripps Research Institute, USA, have been able to identify a cellular pathway used by glioblastoma (GBM) tumours to allow them to survive, that could be exploited therapeutically to halt tumour growth.
-
Grace’s vlog: documenting life with a brain tumour
Grace, 23, recently filmed her first video blog for us where she asked our community for any questions about diagnosis, symptoms and effects and life after surgery. Her honest and heartfelt answers are now documented in a video diary.
-
Our ambitions exceed those of Cancer Research UK
A report today from Cancer Research UK predicts that survival from brain tumours will remain virtually unchanged over the next 20 years, despite an expected fall of 15% overall in the number of cancer deaths by 2035.
-
A research round-up from Dr Paul Brennan at the University of Edinburgh
Dr Paul Brennan, from the University of Edinburgh, shares a round-up of his research with us.
-
Canadian researchers discover cell subgroups in treatment of paediatric ATRT brain cancer
Researchers from Toronto and Montreal have successfully identified three distinct sub-groups of classification of the incurable typical teratoid rhabdoid tumours (ATRTs).
-
Brain tumour patients denied life-extending drug in ‘postcode lottery’
A drug that can extend the lives of brain tumour patients is being withheld by some NHS Trusts on the grounds of cost.
-
New Proton Beam centre begins construction in Reading
Due to be operational in 2018, a new Proton Beam centre has just received planning permission this week. Building work has already begun on the University of Reading’s site for their Thames Valley Science Park.
-
We are proud to announce the formation of our Scientific Advisory Boards
In order to ensure that we fund only the highest quality research, we have formed two Scientific Advisory Boards (SABs) which are made up of internationally renowned scientific and medical experts that work in different areas of cancer research and social science.
-
Research into brain tumours: why money isn’t everything
Beccy Shortt, our Senior Policy and Public Affairs Manager at The Brain Tumour Charity explores the barriers surrounding brain tumour research.
-
New biomarker could improve the diagnosis of diffuse gliomas
Researchers at the University of Texas Southwestern Medical Center in Dallas have identified a gene called SHOX2 that could be used to better diagnose brain tumours.
-
Why we’re investing in new brain tumour fund
“We will always do things differently if it’s the right thing for people affected by a brain tumour. That’s why we’re investing in The Brain Tumour Fund.” – Sarah Lindsell, CEO of The Brain Tumour Charity
-
Julien Baptiste in the BBC One drama The Missing, sheds light on effects of a brain tumour diagnosis
Julien Baptiste’s character, played by acclaimed actor Tchéky Karyo, steered the second series of the award-winning drama with the diagnosis of a brain tumour framing his actions and decisions as a key aspect of the storyline.
-
Headeast Vietnam cycle challenge battle first day typhoon
Lewis Moody MBE, co-Founder of The Foundation and headeast organiser, polar explorer Alan Chambers MBE and 10 other fearless cycling challengers have saddled up in Saigon.
-
Edinburgh research discovers new relationship between immune and glioblastoma cells
Research carried out at the University of Edinburgh has revealed a new alliance between immune cells and glioblastoma tumour cells in zebrafish.
-
Review of Informed Choice released
Patients diagnosed with cancer should be told clearly how the NHS will store and use information about their case to help others in future, says a new report.
-
An unexpected journey
Our Director of Services and Influencing, Emma Tingley, shares her thoughts on navigating the system after a brain tumour diagnosis, and our recently launched Patient Guide.
-
New device ‘extends survival’ for glioblastoma patients, trial finds
A battery-powered cap that disrupts the growth of brain tumour cells could help glioblastoma patients to survive for longer, new findings suggest.
-
Our Patient Guide to Brain Tumour Treatment and Services launches today
Our Patient Guide launches today to help people living with a brain tumour better navigate the healthcare system.
-
First stage of Addenbrooke’s trials of glioblastoma ‘pink drink’ research nears completion
Dr Colin Watts’ research, funded by us, uses fluorescent dye to reveal different parts of glioblastoma tumours during surgery.
-
Unique opportunity for surgery patients to help decode brain tumours
Researchers want to gather tissue samples from people with high-grade brain tumours as part of the groundbreaking Genomics England programme.
-
Walton Centre in Liverpool given top ranking by health watchdog
We’d like to offer our congratulations to all at the Walton Centre in Liverpool, which has just been awarded a rare ‘outstanding’ rating by health watchdog the Care Quality Commission.
-
Brain tumour surgery: experts call for change to improve survival
New research prompts drive to increase specialist neurosurgery access
-
Owain’s story: I couldn’t have played Glen without the charity
“Playing Glen has given me the utmost respect and admiration for people living with a brain tumour.”